Clinical trial · Interventional
Laser Acupoints Stimulation on Xerostomia Related Chemoradiotherapy for Head and Neck Cancer Patients
NCT07029854CI-TRIAL-00091196not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the study is to evaluate to effect of LASER acupoints stimulations on xerostomia patients during chemoradiation therapy after head and neck cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Xerostomia Following Radiotherapy | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| LASER acupoints therapy | Other | — | UNRESOLVED |
| Medical treatment | Other | — | UNRESOLVED |
| Pseudo-LASER acupoints therapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- LASER acupoints therapy + Medical treatment
- description
- This group will include twenty-seven patients suffering xerostomia (dryness of mouth), who will receive LASER acupoints therapy (3 times per week, for 4 weeks), plus medical treatment.
- interventionNames
- Other: Medical treatment
- Other: LASER acupoints therapy
- type
- PLACEBO_COMPARATOR
- label
- Pseudo-LASER acupoints therapy + Medical treatment
- description
- This group will include twenty-seven patients suffering xerostomia (dryness of mouth), who will receive pseudo-LASER acupoints therapy plus medical treatment (for 4 weeks).
- interventionNames
- Other: Medical treatment
- Other: Pseudo-LASER acupoints therapy
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 40 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Chemoradiation therapy * Carcinoma in the head and neck area (NPC) * Anatomically intact parotid and submandibular glands. * All patients will be clinically and medically stable when attending the study. Exclusion Criteria: * They had a history of xerostomia; * They had suspected or confirmed physical closure of salivary gland. * ducts on either side. * They had known bleeding disorders. * They Were taking heparin or warfarin. * They had contraindications for the use of acupuncture at any acupoints. * They had history of cerebrovascular accident or spinal cord injury. * They had taken any drug or herbal medicine in the past 30 days that could affect salivary function. * They were planning to, or ended up taking such a substance during the study. * Any therapy that may affect treatment.
References
Publications (0)
Data not yet available
No reference posted for this study.